Category: Zacks Small Cap Research

1234516730 / 1663 POSTS
By John Vandermosten, CFA NYSE:SQZ READ THE FULL SQZ RESEARCH REPORT On May 10, 2022, SQZ Biotechnologies Company (NYSE:SQZ) reported 1Q:22 financial and operational results in a press release concurrent with the filing of its Form 10-Q. Achievement ...
By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT On May 9, 2022 Lipocine (NASDAQ:LPCN) filed its Form 10-Q and posted its earnings release for the quarter ending March 31, 2022. Highlights for the first quarter 2022 and to-da ...
By David Bautz, PhD NASDAQ:BTAI READ THE FULL BTAI RESEARCH REPORT Business Update IGALMI™ to Launch May 25th, 2022 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is a biopharmaceutical company that recently received its first FDA approval for IGALMI (dexm ...
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Growing Database Supporting Hemopurifier’s Ability to Treat COVID-19Aethlon Medical’s (NASDAQ:AEMD) lead asset, the Aethlon Hemopurifier®, produced positive results in binding seven variants ...
By David Bautz, PhD OTC:VIVXF READ THE FULL VIVXF RESEARCH REPORT Business Update OxC-beta Approved in Vietnam; Looking for Sales Ramp in 2H22 Avivagen, Inc. (OTC:VIVXF) is developing products to support animal health, which includes replacing antibi ...
By Lisa Thompson NASDAQ:OIIM READ THE FULL OIIM RESEARCH REPORT O2Micro’s (NASDAQ:OIIM) Board has received preliminary nonbinding proposal letter, dated March 14th, 2022, from FNOF Precious Honor Limited to acquire all of the outstanding shares of th ...
By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT Recent trends illustrate stability of revenue streams CoreCivic (NYSE:CXW) reported 1Q22 revenue of $453.0 million compared to $454.7 million in 1Q21. Factors behind the slight revenue decline in ...
By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT On May 5, 2022, electroCore Inc. (NASDAQ:ECOR) posted first quarter 2022 financial and operational results in a press release and Form 10-Q filed with the SEC. A conference call ...
By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT After market close on May 3, 2022, MiMedx Group, Inc. (NASDAQ:MDXG) filed Form 10-Q with the SEC and issued a press release summarizing its financial and operational results for ...
By John Vandermosten, CFA NASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT On May 3, 2022, Lantern Pharma, Inc. (NASDAQ:LTRN) announced 1Q:22 annual financial and operational results, filed its Form 10-Q with the SEC and hosted a video webcast to revie ...
1234516730 / 1663 POSTS